July 29, 2014 1:11 AM ET

Health Care Technology

Company Overview of Epocrates, Inc.

Executive Profile

Peter C. Brandt

Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee, Rexahn Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 6 different industries.

See Board Relationships
57$49,417

Background

Mr. Peter C. Brandt served as an Interim Chief Executive Officer and Interim President at Epocrates Inc. from November 16, 2011 to March 27, 2012. Mr. Brandt served as the President and Chief Executive Officer of Noven Pharmaceuticals Inc. since April 2008. He has extensive business and industry experience. He spent 28 years at Pfizer. He served as President - U.S. Pharmaceuticals Operations at Pfizer Inc., where he helped deliver revenue and earnings growth while engineering ...

Corporate Headquarters

1100 Park Place
San Mateo, California 94403

United States

Phone: 650-227-1700
Fax: 650-227-2770

Board Members Memberships

Former Chairman
Member of The Board of Trustees
2008-Present
Director
2010-Present
Director and Member of Audit & Compliance Committee
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2011-2013
Former Chairman and Chairman of Compensation Committee

Education

MBA
Columbia Business School
BA
University of Connecticut

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$28,000
Total Calculated Compensation$49,417
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Epocrates, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.